1-7 of 7
leukemia, myeloid
Close
Sort by
Journal Articles

Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax

Blake S. Moses, Samantha McCullough, Jennifer M. Fox, Bryan T. Mott, Søren M. Bentzen, MinJung Kim, Jeffrey W. Tyner, Rena G. Lapidus, Ashkan Emadi, Michelle A. Rudek, Tami J. Kingsbury, Curt I. Civin
Journal: Blood Advances
Blood Adv (2021) 5 (3): 711–724.
https://doi.org/10.1182/bloodadvances.2020003429
Published: 2021
Includes: Supplemental data
Journal Articles

Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status

Raksha Shrestha, Mamiko Sakata-Yanagimoto, Koichiro Maie, Motohiko Oshima, Masatomo Ishihara, Yasuhito Suehara, Kota Fukumoto, Yaeko Nakajima-Takagi, Hirotaka Matsui, Takayasu Kato, Hideharu Muto, Tatsuhiro Sakamoto, Manabu Kusakabe, Yasuhito Nannya, Hideki Makishima, Hiroo Ueno, Ryunosuke Saiki, Seishi Ogawa, Kenichi Chiba, Yuichi Shiraishi, Satoru Miyano, Enguerran Mouly, Olivier A. Bernard, Toshiya Inaba, Haruhiko Koseki, Atsushi Iwama, Shigeru Chiba
Journal: Blood Advances
Blood Adv (2020) 4 (5): 845–854.
https://doi.org/10.1182/bloodadvances.2019001324
Published: 2020
Includes: Supplemental data
Journal Articles

Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias

Clinical Trials & Observations
Ashwin Sridharan, Carolina D. Schinke, George Georgiev, Mariana Da Silva Ferreira, Victor Thiruthuvanathan, Ian MacArthur, Tushar D. Bhagat, Gaurav S. Choudhary, Srinivas Aluri, Jiahao Chen, Kith Pradhan, Yu Xia, Maya Panjikaran, Gregory Sims, Chirag K. Bhagat, Ryan Bender, Lauryn Keeler, Armin Graber, Christoph Heuck, Frederick A. Fletcher, Daisy Alapat, Niels Weinhold, Sarah K. Johnson, Amittha Wickrema, Bart Barlogie, Gareth J. Morgan, Aditi Shastri, Ulrich Steidl, Britta Will, Amit Verma
Journal: Blood Advances
Blood Adv (2019) 3 (23): 3962–3967.
https://doi.org/10.1182/bloodadvances.2019000731
Published: 2019
Includes: Supplemental data
Journal Articles

The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy

Suhu Liu, Anna E. Marneth, Gabriela Alexe, Sarah R. Walker, Helen I. Gandler, Darwin Q. Ye, Katherine Labella, Radhika Mathur, Patricia A. Toniolo, Michelle Tillgren, Prafulla C. Gokhale, David Barbie, Ann Mullally, Kimberly Stegmaier, David A. Frank
Journal: Blood Advances
Blood Adv (2018) 2 (23): 3428–3442.
https://doi.org/10.1182/bloodadvances.2018016733
Published: 2018
Includes: Supplemental data
Journal Articles

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study

Clinical Trials & Observations
Marius Flasinski, Kira Scheibke, Martin Zimmermann, Ursula Creutzig, Katarina Reinhardt, Femke Verwer, Valerie de Haas, Vincent H. J. van der Velden, Christine von Neuhoff, C. Michel Zwaan, Dirk Reinhardt, Jan-Henning Klusmann
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1532–1540.
https://doi.org/10.1182/bloodadvances.2018018945
Published: 2018
Includes: Supplemental data
Journal Articles

Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice

Jacob T. Jackson, Ashley P. Ng, Benjamin J. Shields, Sue Haupt, Ygal Haupt, Matthew P. McCormack
Journal: Blood Advances
Blood Adv (2018) 2 (4): 347–360.
https://doi.org/10.1182/bloodadvances.2017013243
Published: 2018
Includes: Supplemental data
Journal Articles

Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia

Ikuko Nakamae, Jun-ya Kato, Takashi Yokoyama, Hidenori Ito, Noriko Yoneda-Kato
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1682–1693.
https://doi.org/10.1182/bloodadvances.2017007054
Published: 2017